Page last updated: 2024-09-03

methylthio-adp and Bone Loss, Osteoclastic

methylthio-adp has been researched along with Bone Loss, Osteoclastic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arnett, TR; Burnstock, G; Hoebertz, A; Meghji, S	1

Other Studies

1 other study(ies) available for methylthio-adp and Bone Loss, Osteoclastic

Article	Year
Extracellular ADP is a powerful osteolytic agent: evidence for signaling through the P2Y(1) receptor on bone cells. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2001, Volume: 15, Issue:7 Topics: Adenosine Diphosphate; Animals; Bone and Bones; Bone Resorption; Calcium; Cells, Cultured; Chondrocytes; Immunohistochemistry; In Situ Hybridization; Mice; Osteoblasts; Osteoclasts; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Signal Transduction; Thionucleotides	2001

Article

Year

Extracellular ADP is a powerful osteolytic agent: evidence for signaling through the P2Y(1) receptor on bone cells.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2001, Volume: 15, Issue:7

Topics: Adenosine Diphosphate; Animals; Bone and Bones; Bone Resorption; Calcium; Cells, Cultured; Chondrocytes; Immunohistochemistry; In Situ Hybridization; Mice; Osteoblasts; Osteoclasts; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Signal Transduction; Thionucleotides

2001